In four cases (Table 2, samples 6, 9, 17 and 18), HER2 protein expression by immunohistochemistry showed a similar trend towards higher scores in DCIS as the one observed for gene expression studies (Fig. 4b and Table 2). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.